What Can AACR Do to Prevent Cancer? Insights From the AACR Cancer Prevention Summit
With the theme of “Shaping the Future of Cancer Prevention: A Roadmap for Integrative Cancer Science and Public Health,”...
Category: Meetings
With the theme of “Shaping the Future of Cancer Prevention: A Roadmap for Integrative Cancer Science and Public Health,”...
Last year saw significant progress against lung cancer, with seven new therapeutics, including two immunotherapeutics, approved by the U.S....
Breast cancer researchers are packed up in San Antonio, eager to build on the latest information they gathered at...
Breast cancer recurrence rates were similar for postmenopausal women with estrogen receptor-positive DCIS whether they took anastrozole or tamoxifen,...
T-DM1, a HER2-targeted antibody-drug conjugate, improved outcomes for patients with HER2-positive, metastatic breast cancer that had progressed despite prior...
Breast-conserving surgery may be a better option than mastectomy for patients with early-stage breast cancer.
Adding denosumab (Xgeva) to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal women with early-stage hormone receptor-positive breast...
Studies presented at this year’s San Antonio Breast Cancer Symposium shed light on new investigational therapies for patients with...
The AACR’s disparities conference covered a wide array of issues this year, from the biological factors that make some...
Kimberly Stegmaier, MD, co-director of the pediatric hematologic malignancy program and associate professor of pediatrics at Dana-Farber Cancer Institute...